Cantil

Active Ingredient(s): Mepenzolate
FDA Approved: * November 14, 1956
Pharm Company: * SANOFI AVENTIS US
Category: Ulcer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Cantil Overview

Mepenzolate is an antimuscarinic.[1] References .mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{...

Read more Cantil Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Mepenzolate

Recent Cantil Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Mepenzolate
  • Solution: 25mg/5ml
  • Tablet: 25mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cantil: (1 result)

Sorted by National Drug Code
  • 0068-0037 Cantil 25 mg Oral Tablet by Sanofi-aventis U.S. LLC

Other drugs which contain Mepenzolate or a similar ingredient: (1 result)